Sign Up to like & get
recommendations!
0
Published in 2020 at "Cancer Gene Therapy"
DOI: 10.1038/s41417-020-0167-x
Abstract: Surgical resection is the only cure for neuroendocrine tumors (NETs). However, widespread metastases have already occured by the time of initial diagnosis in many cases making complete surgical removal impossible. We developed a recombinant heavy-chain…
read more here.
Keywords:
botulinum neurotoxin;
rhcr;
neuroendocrine tumors;
monomethyl auristatin ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Molecular Neuroscience"
DOI: 10.3389/fnmol.2022.909835
Abstract: Well-established efficacy of botulinum neurotoxin type A (BoNT/A) in aesthetic dermatology and neuromuscular hyperactivity disorders relies on canonical interruption of acetylcholine neurotransmission at the neuromuscular junction at the site of the injection. The mechanisms and…
read more here.
Keywords:
efficacy;
inflammatory pain;
pain;
botulinum neurotoxin ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Antibodies"
DOI: 10.3390/antib11010021
Abstract: Botulinum neurotoxin type E (BoNT/E), the fastest acting toxin of all BoNTs, cleaves the 25 kDa synaptosomal-associated protein (SNAP-25) in motor neurons, leading to flaccid paralysis. The specific detection and quantification of the BoNT/E-cleaved SNAP-25…
read more here.
Keywords:
highly specific;
antibody;
snap neoepitope;
botulinum neurotoxin ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Toxins"
DOI: 10.3390/toxins13110817
Abstract: Intradermal injection of botulinum neurotoxin is a frequently performed procedure in aesthetic dermatology to improve facial skin tone, texture, fine wrinkles, and enlarged pores. In practice, botulinum neurotoxin type A is also used to reduce…
read more here.
Keywords:
botulinum;
botulinum neurotoxin;
evidence;
neurotoxin type ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Toxins"
DOI: 10.3390/toxins14080564
Abstract: Botulinum Neurotoxin type-A (BoNT-A) is the treatment of choice for focal post-stroke spasticity (PSS). Due to its mechanism of action and the administration method, some authors raised concern about its possible systemic diffusion leading to…
read more here.
Keywords:
stroke spasticity;
stroke;
post stroke;
botulinum neurotoxin ... See more keywords